Hipertensión arterial y enfermedad de Alzheimer

Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longit...

Descripción completa

Detalles Bibliográficos
Autor: Coll de Tuero, Gabriel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2010
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10256/7541
Acceso en línea:http://hdl.handle.net/10256/7541
Access Level:acceso abierto
Palabra clave:Hipertensió
Hypertension
Alzheimer, Malaltia d' -- Tractament
Alzheimer's disease -- Treatment
id ES_6754ae2cb73cb5b41d98fe2cedc7af20
oai_identifier_str oai:recercat.cat:10256/7541
network_acronym_str ES
network_name_str España
repository_id_str
spelling Hipertensión arterial y enfermedad de AlzheimerColl de Tuero, GabrielHipertensióHypertensionAlzheimer, Malaltia d' -- TractamentAlzheimer's disease -- TreatmentHypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studiesEditorial Glosa2010info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10256/7541http://hdl.handle.net/10256/7541© Alzheimer. Realidades e investigación en demencia, 2010, núm. 45, p. 30-39Articles publicats (D-CM)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)Inglésinfo:eu-repo/semantics/altIdentifier/issn/1137-1242Tots els drets reservatsinfo:eu-repo/semantics/openAccessoai:recercat.cat:10256/75412026-05-29T05:05:01Z
dc.title.none.fl_str_mv Hipertensión arterial y enfermedad de Alzheimer
title Hipertensión arterial y enfermedad de Alzheimer
spellingShingle Hipertensión arterial y enfermedad de Alzheimer
Coll de Tuero, Gabriel
Hipertensió
Hypertension
Alzheimer, Malaltia d' -- Tractament
Alzheimer's disease -- Treatment
title_short Hipertensión arterial y enfermedad de Alzheimer
title_full Hipertensión arterial y enfermedad de Alzheimer
title_fullStr Hipertensión arterial y enfermedad de Alzheimer
title_full_unstemmed Hipertensión arterial y enfermedad de Alzheimer
title_sort Hipertensión arterial y enfermedad de Alzheimer
dc.creator.none.fl_str_mv Coll de Tuero, Gabriel
author Coll de Tuero, Gabriel
author_facet Coll de Tuero, Gabriel
author_role author
dc.subject.none.fl_str_mv Hipertensió
Hypertension
Alzheimer, Malaltia d' -- Tractament
Alzheimer's disease -- Treatment
topic Hipertensió
Hypertension
Alzheimer, Malaltia d' -- Tractament
Alzheimer's disease -- Treatment
description Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studies
publishDate 2010
dc.date.none.fl_str_mv 2010
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10256/7541
http://hdl.handle.net/10256/7541
url http://hdl.handle.net/10256/7541
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/issn/1137-1242
dc.rights.none.fl_str_mv Tots els drets reservats
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Tots els drets reservats
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Editorial Glosa
publisher.none.fl_str_mv Editorial Glosa
dc.source.none.fl_str_mv © Alzheimer. Realidades e investigación en demencia, 2010, núm. 45, p. 30-39
Articles publicats (D-CM)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869409882039386112
score 15.811543

Similares en LA Referencia